---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-23-028008"
form_type: "8-K"
ticker: "HCWB"
cik: "0001828673"
company_name: "HCW Biologics Inc."
filed_at: "2023-06-14T23:59:59+00:00"
generated_at: "2026-06-14T01:31:40.814734+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# HCW Biologics stockholders elect directors and ratify auditor at 2023 annual meeting

## Summary
- Lisa M. Giles and Rick S. Greene elected Class II directors with 18.9M and 18.8M votes for, respectively.
- Ratification of Grant Thornton LLP as independent auditor: 21.6M for, 3,374 against, 45,063 abstain.
- Broker non-votes of 2,228,627 on director elections; none on auditor ratification.

## SEC filing metadata
- accession: 0000950170-23-028008
- form_type: 8-K
- ticker: HCWB
- cik: 0001828673
- company_name: HCW Biologics Inc.
- filed_at: 2023-06-14T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1828673/000095017023028008/0000950170-23-028008-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1828673/000095017023028008/hcwb-20230613.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-23-028008
- JSON: https://secwatch.observer/filing/0000950170-23-028008.json
- Plain text: https://secwatch.observer/filing/0000950170-23-028008.txt

## Key facts
- Shareholder Votes
  HCW Biologics Inc. shareholders approved Election of two Class II directors, each to serve for a three-year term expiring at the 2026 Annual Meeting of Stockholders at the 2023-06-13 meeting.
  - Proposal: director election
  - Outcome: passed
  - Meeting: 2023-06-13
  source text: The Company’s stockholders approved the election of two Class II directors, each to serve for a three-year term expiring at the 2026 Annual Meeting of Stockholders or until such director's successor is duly elected and qualified or until such director's earlier death, resignation, disqualification or removal: Nominee For Withheld Broker Non-Votes Lisa M. Giles 18,867,295 503,344 2,228,627 Rick S. Greene 18,857,446 513,193 2,228,627
  evidence_url: https://www.sec.gov/Archives/edgar/data/1828673/000095017023028008/0000950170-23-028008-index.htm
- Shareholder Votes
  HCW Biologics Inc. shareholders approved Ratification of the appointment of Grant Thornton LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2023 at the 2023-06-13 meeting.
  - Proposal: auditor ratification
  - Outcome: passed
  - Meeting: 2023-06-13
  source text: The Company’s stockholders ratified the appointment of Grant Thornton LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2023: For Against Abstain Broker Non-Votes 21,550,829 3,374 45,063 N/A
  evidence_url: https://www.sec.gov/Archives/edgar/data/1828673/000095017023028008/0000950170-23-028008-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.